InfuSystem Holdings, Inc., a medical technology company, disclosed on July 28, 2026, that it will release its second quarter 2026 financial results on Tuesday, August 4, 2026, before market opening, followed by a conference call at 9:00 a.m. Eastern Time. The announcement provides investors with the timing and format for access to the company's latest quarterly performance metrics and management commentary. This disclosure represents routine quarterly earnings communication designed to ensure broad investor access to financial information.

Key Points

  • NYSE: INFU
  • InfuSystem Holdings announced its second quarter 2026 financial results will be released on August 4, 2026, before market open
  • A conference call for investors is scheduled for August 4, 2026, at 9:00 a.m. Eastern Time
  • The announcement was made via press release on July 28, 2026

Earnings Release Timing and Disclosure Schedule

InfuSystem Holdings disclosed that its second quarter 2026 financial results will become public on Tuesday, August 4, 2026, prior to the opening of regular trading hours. This timing allows investors and market participants to review the company's quarterly performance before the markets open, enabling informed trading decisions at the start of the trading day. The pre-market release of earnings information represents standard practice for publicly traded companies seeking to provide simultaneous access to financial results across investor groups.

The company's disclosure indicates the results will cover the second quarter period and will include the financial performance data and key metrics for that timeframe. By releasing before market open, InfuSystem Holdings ensures that institutional investors, retail shareholders, and financial analysts can evaluate the same information at the same time, reducing information asymmetry in the marketplace.

Conference Call Access and Investor Communication

Following the financial results release, InfuSystem Holdings will conduct a live conference call on August 4, 2026, at 9:00 a.m. Eastern Time. This call will be available to all interested investors, providing an opportunity for shareholders and market participants to hear directly from company management regarding second quarter performance and to ask questions about the results. Conference calls of this nature typically feature remarks from senior executives followed by a question-and-answer session with research analysts and investors.

The scheduling of the call on the same day as the earnings release allows investors to have context from the financial statements before listening to management commentary. This integrated approach to quarterly communication helps ensure that investors can form a comprehensive understanding of the company's operational and financial performance for the period being reported.

InfuSystem Holdings Business Overview

InfuSystem Holdings, Inc., is a Delaware corporation with principal executive offices located in Rochester Hills, Michigan. The company is registered on NYSE American LLC under the trading symbol INFU. The organization operates in the medical technology sector and maintains regular public disclosure obligations to its shareholders and the broader investment community through Securities and Exchange Commission filings and periodic announcements.

As a publicly traded company, InfuSystem Holdings is subject to quarterly reporting requirements and investor communication protocols established by securities regulations. The company's commitment to scheduled earnings announcements and investor calls reflects its obligation to maintain transparent communication with shareholders and the investment community regarding its financial performance and business operations.

Regulation FD Disclosure Framework

The company's announcement on July 28, 2026, was made in accordance with Regulation Fair Disclosure (FD), a Securities and Exchange Commission rule designed to ensure that publicly traded companies distribute material information to all investors simultaneously. The disclosure was furnished through a press release rather than filed as a separate formal document, which means it is provided for informational purposes without triggering certain liability provisions under securities law.

The company specifically noted that the information furnished under Item 7.01 of its disclosure shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be incorporated by reference into other company filings under the Securities Act of 1933 or the Securities Exchange Act of 1934. This technical distinction is standard practice for routine announcements of publicly scheduled events such as earnings releases and conference calls.

Press Release and Supporting Documentation

InfuSystem Holdings attached its July 28, 2026, press release as Exhibit 99.1 to its disclosure, providing formal documentation of the announcement to the market. The press release serves as the official communication vehicle for notifying investors and financial media of the upcoming earnings release and conference call dates. This approach ensures that all market participants receive consistent and identical information regarding the company's disclosure schedule.

The supporting documentation filed with the disclosure also includes an interactive data file embedded within the Inline XBRL document format, which is the standard electronic filing format used by public companies to submit regulatory documents to the Securities and Exchange Commission. This standardized format facilitates automated data processing and analysis by investors, regulators, and financial information providers.

Timeline for Investor Action

Investors and stakeholders interested in following InfuSystem Holdings' second quarter 2026 performance should mark their calendars for Tuesday, August 4, 2026. The financial results will become available before market open, allowing investors to review the numbers before trading begins. The 9:00 a.m. Eastern Time conference call will follow, providing an opportunity for real-time engagement with company management regarding the results.

This schedule provides investors with ample opportunity to gather information, form opinions, and make investment decisions based on the company's disclosed financial performance. The timing of these disclosure events is designed to provide maximum transparency and market efficiency by ensuring broad, simultaneous access to material information about the company's quarterly results.

Executive Certification and Filing Authority

The disclosure was signed on behalf of InfuSystem Holdings by Carrie Lachance, who serves as Chief Executive Officer and Director of the company. Her signature on the filing certifies that the document has been authorized by appropriate corporate officers and has been duly executed in accordance with Securities and Exchange Commission requirements. This certification provides assurance that the disclosure has been prepared and submitted in compliance with applicable securities regulations.

The signing of the document on July 28, 2026, the same date as the announcement, indicates that the disclosure was processed and filed promptly following the company's decision to announce its earnings schedule to the investment community. The formal execution by a senior corporate officer reflects the significance and authenticity of the disclosure.

Corporate Filing Details and Registration Information

InfuSystem Holdings' regulatory filings with the Securities and Exchange Commission are maintained under Commission File Number 001-35020 and IRS Employer Identification Number 20-3341405. The company's common stock, with a par value of $0.0001 per share, trades on NYSE American LLC under the symbol INFU. These identifiers allow investors and regulators to locate and track the company's official securities filings and regulatory submissions.

The company is not classified as an emerging growth company for purposes of Securities and Exchange Commission regulations. This designation means InfuSystem Holdings is subject to the full range of public company reporting and disclosure requirements without utilizing extended transition periods that may be available to smaller emerging growth companies. The company's full regulatory filing history and additional disclosures are available through the SEC's EDGAR database.

What Investors Should Monitor Following This Announcement

Investors should prepare for the release of InfuSystem Holdings' second quarter 2026 financial results on August 4, 2026, by reviewing the company's most recent financial reports and understanding the key operational and financial metrics the company typically reports. Comparing current quarter results to prior period performance and analyst expectations will provide context for evaluating the company's progress.

During the conference call on August 4, 2026, at 9:00 a.m. Eastern Time, investors may be watching for management commentary regarding revenue trends, operating margins, capital expenditures, and guidance regarding future financial performance. The question-and-answer portion of the call will offer investors direct insight into management's perspective on competitive conditions, market opportunities, and operational challenges facing the business.